|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jul 31, 2021 |
Title |
3M_Dup_clone_5_rep_2 |
Sample type |
SRA |
|
|
Source name |
3M cerebral organoids
|
Organism |
Homo sapiens |
Characteristics |
tissue: 3M cerebral organoids 16p11.2 cnv: DUPLICATION disease state: autism
|
Growth protocol |
iPSCs: To generate induced pluripotent stem cells (iPSCs), skin fibroblasts were infected with Sendai virus vectors containing coding sequences of human OCT4, SOX2, KLF4 and c-MYC (Cytotune reprogramming kit, Thermo Fisher). Four days post infection, fibroblasts were trypsinized to single cells, plated on the inactivated mouse embryonic fibroblast feeders, and cultured using human embryonic stem cell medium (vendor?). After 3–4 weeks, iPSC clones were manually picked and propagated clonally on feeders. After 8-10 passages, iPSCs were transferred to a feeder-free system and grown on matrigel-coated dishes (Corning) in mTeSR1 media (StemCell Technologies). The cells were passaged by manually picking colonies. Cerebral organoids: Feeder-free iPSCs at passage 15 or later were fed daily with mTeSR1 for at least 7 days before differentiation. Colonies were dissociated using Accutase (Life Technologies) in PBS (1:1) for 10 minutes at 37°C and centrifuged for 3 minutes at 100xg. The cell pellet was resuspended in mTeSR1 supplemented with 10 μM SB431542 (SB, Tocris) and 1 μM Dorsomorphin (Dorso, R&D Systems). Approximately 5 × 106 cells were transferred to each well of a 6-well plate and kept in suspension under rotation (95 rpm) in the presence of 5 μM ROCK inhibitor (StemCell Technologies) for 24 hours to form free-floating spheres. Then, the media was replaced with mTeSR1 for additional 48 hours. After 72 hours, Media1 [Neurobasal (Life Technologies) supplemented with Glutamax, 2% Gem21 NeuroPlex (Gemini Bio-Products), 1% N2 NeuroPlex (Gemini Bio-Products), 1% MEM nonessential amino acids (NEAA, Life Technologies), 1% penicillin/streptomycin (PS; LifeTechnologies), 10 μM SB and 1 μM Dorso] was used for maintenance for 7 days, with media changes every other day. Subsequently, Media1 was replaced with Media2 [Neurobasal with Glutamax, 2% Gem21 NeuroPlex, 1% NEAA and 1% PS] supplemented with 20 ng/mL FGF2 (Life Technologies) for additional 7 days. Then, Media2 was supplemented with both 20 ng/mL FGF2 and 20 ng/mL EGF (Life Technologies) and spheres were cultured for additional 7 days with media changes every other day. Next, organoids were transferred into Media3 [Media2 supplemented with 10 ng/mL BDNF, 10 ng/mL GDNF, 10 ng/mL NT-3 (all from Life Technologies), 200 μM L-ascorbic acid (Tocris) and 1 mM dibutyryl-cAMP (StemCell Technologies)] for another 7 days with media changes every other day. After 28 days, cortical organoids were maintained in Media2 for as long as needed, with media changes every 3-4 days. All organoids were generated, grown and used for all experiments in the same plate with one DEL, one DUP and one CTRL (called a “batch” thereafter) to reduce batch effect from genotypes.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA-seq libraries were prepared using standard Illumina protocols
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 4000 |
|
|
Data processing |
Illumina RTA version 2.7.6 software used for basecalling. All fastqs were trimmed for adapter sequence and low base call quality (Phred score < 30 at ends) using Cutadapt (v1.14). Trimmed reads were then aligned to the GRCH37.p13 (hg19) reference genome via STAR (2.5.3a) using comprehensive gene annotations from Gencode (v19). Gene-level quantifications were calculated using RSEM (v1.3). Genome_build: Human GRCH37.p13 (hg19) reference genome Supplementary_files_format_and_content: count matrix with rows as genes (EnsembIDs) and columns as samples
|
|
|
Submission date |
Dec 17, 2019 |
Last update date |
Jul 31, 2021 |
Contact name |
Lilia M Iakoucheva |
E-mail(s) |
lilyak@health.ucsd.edu
|
Phone |
(858)-822-1878
|
Organization name |
University of California San Diego
|
Department |
Psychiatry
|
Lab |
Iakoucheva
|
Street address |
9500 Gilman Drive, MC0603
|
City |
La Jolla |
State/province |
California |
ZIP/Postal code |
92093 |
Country |
USA |
|
|
Platform ID |
GPL20301 |
Series (1) |
GSE142174 |
Cortical organoids model early brain development disrupted by 16p11.2 CNV in autism |
|
Relations |
BioSample |
SAMN13614611 |
SRA |
SRX7396862 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|